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Abstract. 
 
The mammalian nuclear pore complex 
 
(NPC) is comprised of 
 
z
 
50 unique proteins, collectively 
known as nucleoporins. Through fractionation of rat 
liver nuclei, we have isolated 
 
.
 
30 potentially novel nu-
cleoporins and have begun a systematic characteriza-
tion of these proteins. Here, we present the character-
ization of Nup96, a novel nucleoporin with a predicted 
molecular mass of 96 kD. Nup96 is generated through 
an unusual biogenesis pathway that involves synthesis 
of a 186-kD precursor protein. Proteolytic cleavage of 
the precursor yields two nucleoporins: Nup98, a previ-
ously characterized GLFG-repeat containing nucle-
oporin, and Nup96. Mutational and functional analyses 
demonstrate that both the Nup98-Nup96 precursor and 
the previously characterized Nup98 (synthesized inde-
pendently from an alternatively spliced mRNA) are 
proteolytically cleaved in vivo. This biogenesis pathway 
for Nup98 and Nup96 is evolutionarily conserved, as 
the putative 
 
Saccharomyces cerevisiae 
 
homologues,
N-Nup145p and C-Nup145p, are also produced through 
proteolytic cleavage of a precursor protein. Using im-
munoelectron microscopy, Nup96 was localized to the 
nucleoplasmic side of the NPC, at or near the nucleo-
plasmic basket. The correct targeting of both Nup96 
and Nup98 to the nucleoplasmic side of the NPC was 
found to be dependent on proteolytic cleavage, suggest-
ing that the cleavage process may regulate NPC assem-
bly. Finally, by biochemical fractionation, a complex 
containing Nup96, Nup107, and at least two Sec13-
related proteins was identiﬁed, revealing that a major 
sub-complex of the NPC is conserved between yeast 
and mammals.
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OR
 
 proteins and RNAs to traffic between the nu-
cleus and the cytoplasm of eukaryotic cells, they
must pass through large supramolecular structures in
the nuclear membrane known as nuclear pore complexes
(NPCs).
 
1
 
 The selection of substrates for transport serves as
an important point for controlling cell functions, and con-
siderable interest has been focused on understanding how
specific substrates are recognized and targeted to NPCs
(for review see Mattaj and Englmeier, 1998; Pemberton et
al., 1998). Peptide motifs (or possibly RNA sequences in
some cases) present in selected cargo function as nuclear
localization signals (NLSs), or nuclear export signals (NESs;
for review see Boulikas, 1993). These signals are recog-
nized and bound by soluble receptors known as karyo-
pherins (or importins and exportins), that function to tar-
get the substrates to the NPC. The lysine/arginine-rich
NLS motifs first identified in the SV-40 large T antigen
(Kalderon et al., 1984) and in nucleoplasmin (Robbins et al.,
1991) are among the best characterized nuclear transport
signals, and all proteins having this type of NLS appear to
be transported into the nucleus by a common pathway
using a karyopherin heterodimer consisting of karyo-
pherin 
 
a
 
 and karyopherin 
 
b
 
1. However, it is now clear that
there are distinct transport pathways, using distinct NLSs
and NESs and cognate karyopherins (see Pemberton et
al., 1998). However, each of these pathways converges at
the NPC where the receptor/substrate complexes bind and
are transported across the nuclear envelope in an energy
dependent process. The mechanism by which the sub-
strate/receptor complexes are translocated through the
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NPC is still poorly defined. Efforts to understand the regu-
lation of this process have focused on two areas: the role of
the small GTPase Ran and its regulatory factors (for re-
views, see Rush et al., 1996; Melchior and Gerace, 1998),
and the structure and function of the NPC itself.
At 125 million daltons, the vertebrate NPC is 
 
z
 
30 times
the size of a ribosome (Reichelt et al., 1990). Three-dimen-
sional structures of the NPCs from 
 
X. laevis
 
 oocytes have
been determined at 
 
z
 
9 nm resolution and reveal a central
cylinder (or transporter), surrounded by a spoke-ring com-
plex that serves to anchor the cylinder in the nuclear enve-
lope (Hinshaw et al., 1992; Akey and Radermacher, 1993).
Attached to both the cytoplasmic and nucleoplasmic faces
of the NPC are filaments that extend 50–100 nm (or more)
away from the NPC (Goldberg and Allen, 1996; Cordes et
al., 1997). On the nucleoplasmic face of the NPC, these fil-
aments form a basket-like structure that likely has an im-
portant role in mRNA export (Ris, 1991; Kiseleva et al.,
1996).
The mammalian NPC is composed of 
 
z
 
50 unique pro-
teins, known collectively as nucleoporins (for reviews see
Rout and Wente, 1994; Bastos et al., 1995). In vertebrates,
the task of identifying and characterizing the majority of
the nucleoporins has only started, as less than one-third
have been analyzed at the molecular level. The character-
ization of this small subset of nucleoporins has, however,
provided considerable insights into the structure and func-
tion of the NPC. Among the first characterized nucleopor-
ins are a family containing the highly repeated peptide
motifs, FXFG and FG (Davis and Blobel, 1986; Sukegawa
and Blobel, 1993; Kraemer et al., 1994; Yokoyama et al.,
1995; Wu et al., 1995; Hu et al., 1996). Several of these
repeat-containing nucleoporins are localized asymmetri-
cally to either the cytoplasmic, or nucleoplasmic sides of
the NPC. Nup358 and Nup214, for example, are associated
with the filaments on the cytoplasmic face of the NPC
(Kraemer et al., 1994; Yokoyama et al., 1995; Wu et al.,
1995), whereas Nup98 and Nup153 are located at or near
the nucleoplasmic basket (Sukegawa et al., 1993; Radu et al.,
1995). p62, on the other hand, forms a complex with three
other FXFG/FG-containing nucleoporins, and this com-
plex localizes to both sides of the NPC, near the central
transporter (Guan et al., 1995; Hu et al., 1996). Because in-
dividual NPCs are presumed to function in both nuclear
import and nuclear export, the distribution of these pro-
teins could be an important determinant of the direction-
ality of transport.
Interactions between karyopherin–substrate complexes
and components of the NPC have provided insight into
how translocation through the NPC may occur. In vitro
binding assays have established that karyopherin–sub-
strate complexes bind, in a regulated manner, to the subset
of FXFG/FG-containing nucleoporins (Moroianu et al.,
1995; Radu et al., 1995; Rexach and Blobel, 1995). This
finding, along with the distribution of the repeat-contain-
ing nucleoporins along the entire length of the NPC, has
suggested that substrates are translocated through the
NPC by a series of association and dissociation reactions
(Moroianu et al., 1995; Radu et al., 1995; Rexach and Blo-
bel, 1995). These reactions are likely to be coordinated by
Ran and its regulators (reviewed in Rush et al., 1996; Mel-
chior and Gerace, 1998), but the exact mechanisms that
 
give rise to vectorial transport through the NPC remain
unknown. Furthermore, it is unlikely that the NPC is sim-
ply a passive and stationary player in the translocation
process. Whereas small particles (
 
,
 
70 Å in diameter) are
able to diffuse through the NPC, particles of 
 
,
 
250 Å in
diameter are transported in a signal-mediated process
(Paine et al., 1975; Dworetzky et al., 1988). These findings
suggest a regulated dilation, or gating of the NPC during
transport. Experiments by Feldherr and Akin (1997) have
suggested that a single gate may exist near the center of
the central transporter, whereas others have observed po-
tential gates at both the nucleoplasmic and cytoplasmic
ends of the transporter that open during RNP export
(Kiseleva et al., 1998). In addition to the possible gating of
the central transporter, dramatic conformational changes
in the nucleoplasmic basket-like structure of the NPC
have also been observed during RNP export, again sug-
gesting a dynamic, rather than passive NPC. No data is yet
available as to the mechanisms regulating the central
transporter or the nucleoplasmic basket, in large measure
due to the lack of information concerning the molecular
composition and organization of these structures.
To obtain a more complete understanding of the com-
position and function of the NPC, we have developed a
procedure for identifying and purifying nucleoporins from
rat liver nuclei. Using this purification procedure, we have
isolated 
 
z
 
30 novel nucleoporins and have begun to char-
acterize them at the molecular level. Here, we report the
characterization of a 96-kD nucleoporin, termed Nup96.
We demonstrate that Nup96 is synthesized as a 186-kD
precursor, and that proteolytic cleavage of this precursor
gives rise to two nucleoporins, Nup96 and Nup98. In addi-
tion, we show that the previously characterized Nup98,
which is produced independently from an alternatively
spliced mRNA, is also proteolytically processed. Like
Nup98, Nup96 was localized to the nucleoplasmic side of
the NPC, possibly associated with the nucleoplasmic bas-
ket. Through mutational and functional analysis, we found
that proteolytic processing is required for the correct tar-
geting of both Nup98 and Nup96 to the NPC. The appar-
ent yeast homologue of the Nup96-Nup98 precursor, 
 
S.
cerevisiae
 
 Nup145p, is also proteolytically processed to
generate two nucleoporins (Dockendorff, 1997; Emtage
et al., 1997; Teixeira et al., 1997), indicating that this bio-
genesis pathway is evolutionarily conserved. Moreover, a
complex containing Nup107 (the yeast Nup84p homo-
logue), Nup96 (the yeast C-Nup145p homologue) and two
Sec13-related proteins was identified. A similar complex
has been described in yeast, indicating that not only the
processing of Nup96, but also its incorporation into a spe-
cific sub-domain of the NPC, is conserved between yeast
and mammals.
 
Materials and Methods
 
Isolation and Fractionation of Rat Liver
Nuclear Envelopes
 
Rat liver nuclei were isolated as described (Blobel and Potter, 1966) and
stored frozen at 
 
2
 
80
 
8
 
C in 100 unit aliquots (1 U 
 
5 
 
3 
 
3 
 
10
 
6
 
 nuclei). Nu-
clear envelopes were prepared by a modification of the procedure de-
scribed by Dwyer and Blobel (1976). Nuclei were thawed and pelleted at 
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500 rpm in a tabletop microfuge for 1 min. After removing the superna-
tant, the pellet was resuspended to a final concentration of 100 U/ml by
drop-wise addition of cold buffer A (0.1 mM MgCl
 
2
 
, protease inhibitors
[0.5 mM phenylmethanesulfonyl fluoride {PMSF}, 1 
 
m
 
g/ml leupeptin, 1 
 
m
 
g/
ml pepstatin A, and 18 
 
m
 
g/ml aprotinin], 5 
 
m
 
g/ml DNase I [Sigma Chemi-
cal Co.], and 5 
 
m
 
g/ml RNase A [Sigma Chemical Co.]) with constant vor-
texing. The nuclei were then immediately diluted to 20 U/ml by addition
of ice-cold buffer B (10% sucrose, 20 mM triethanolamine (pH 8.5), 0.1
mM MgCl
 
2
 
, 1 mM DTT and protease inhibitors), again with constant vor-
texing. The suspension was dounced four times in a glass dounce homoge-
nizer (tight pestle) and incubated at room temperature for 15 min. After
the 15-min incubation, the suspension was underlaid with 5 ml of ice-cold
buffer C (30% sucrose, 20 mM triethanolamine, pH 7.5, 0.1 mM MgCl
 
2
 
, 1
mM DTT and protease inhibitors) and centrifuged at 4,100 
 
g
 
 in a swinging
bucket rotor (Sorvall type HB-4) for 15 min at 4
 
8
 
C. After removing the su-
pernatant and sucrose cushion, the pellet was resuspended to a final con-
centration of 100 U/ml in ice-cold buffer D (10% sucrose, 20 mM trietha-
nolamine, pH 7.5, 0.1 mM MgCl
 
2
 
, 1 mM DTT and protease inhibitors).
The suspension was dounced as above, and diluted to 66 U/ml by addition
of cold buffer D containing 0.3 mg/ml heparin (Sigma Chemical Co.). The
suspension was immediately underlaid with 5 ml of buffer C and pelleted
as above. The pellet resulting from this second extraction is operationally
defined as the nuclear envelope fraction. After removing the supernatant
and sucrose cushion, the pellet was resuspended to a final concentration
of 100 U/ml in ice-cold buffer D. The suspension was dounced as above
and diluted to 66 U/ml by addition of cold buffer D containing 3% Triton
X-100 and 0.075% SDS. The suspension was immediately underlaid with 5
ml of buffer C and pelleted as above. The pellet resulting from this second
extraction is operationally defined as the pore complex lamina fraction
(PCLF). The PCLF was resuspended in cold buffer D at 100 U/ml,
dounced as above, and diluted to 66 U/ml with buffer D containing 0.9%
Empigen BB (Calbiochem-Novabiochem). Samples were incubated on ice
for 5 min and subsequently pelleted for 15 min at 15,000 
 
g
 
 for 15 min. The
supernatant fraction, containing nucleoporins minus the nuclear lamins,
was precipitated with 10% TCA. Precipitated proteins were resuspended
in sample buffer, and the equivalent of 10 U of nuclei were analyzed by
Coomassie blue staining.
 
Isolation of the Nup96/Nup107 Sub-Complex
 
The PCLF was isolated as described above and resuspended (1,000 U/ml)
in buffer D plus 1% Triton X-100, 0.025% SDS, and 0.1 mg/ml heparin.
After resuspension, the samples were immediately spun at 15,000 
 
g
 
 for 10
min at 4
 
8
 
C. The supernatant was then loaded onto a 10–40% sucrose gra-
dient (triethanolamine pH 7.5, 0.1 mM MgCl
 
2
 
) and spun at 40,000 rpm in a
Beckman SW 41 rotor for 17 h at 4
 
8
 
C. 750-
 
m
 
l fractions were collected,
TCA precipitated and analyzed by SDS-PAGE and subsequent silver
staining, or immunoblotting.
 
cDNA Cloning and Plasmid Construction
 
All clones and constructs were sequenced by the Rockefeller University
Protein/DNA Technology Center using an ABI automated DNA se-
quencer. To isolate cDNAs encoding for Nup96, a 48-nucleotide (nt) ss-
DNA probe was synthesized based on the region of clone GM2B8 (kindly
provided by Dr. Mark Rutherford, University of Minnesota,
 
 
 
St. Paul) cod-
ing for the sequenced peptide “LVVRHLASDAIINENYD” (Yang et al.,
1995). This oligonucleotide probe was used to screen a HeLa cDNA li-
brary (kindly provided by Dr. Jian Wu, Rockefeller University, New
York). Two classes of cDNA clones, differing by a 225-nt insert, were ob-
tained in approximately equal numbers. All of the isolated clones had
incomplete 5
 
9
 
 ends, and 5
 
9
 
 RACE was therefore performed using human
fetal liver cDNA (Clontech Laboratories) as template. The 5
 
9
 
 RACE
product and the longest clone obtained from the HeLa cDNA library
were assembled at an overlapping ACC I site, and the full-length clone
was then ligated into the SalI and NotI sites of a modified pAlter-MAX
vector (Promega Corp.) containing an in-frame myc epitope tag. Modified
myc-pAlter-MAX, containing the myc epitope tag, has been previously
described (Matunis et al., 1998).
Myc-tagged Nup96 was generated by PCR using the wild-type Nup98-
Nup96 cDNA as template. An oligonucleotide complementary to the 5
 
9
 
end of the Nup96 ORF (beginning with serine 864) and containing a SalI
site was used in conjunction with an antisense oligonucleotide comple-
mentary to sequences at the 3
 
9
 
 end of the Nup98-Nup96 ORF and con-
taining a NotI site. The resulting PCR product was digested with SalI and
NotI and ligated into the SalI/NotI sites of myc-pAlter-MAX. The myc-
tagged, full-length Nup98 was generated using a similar PCR based ap-
proach using the Nup98-Nup96 cDNA as template. An oligonucleotide
complementary to the 5
 
9
 
 end of the Nup98-Nup96 ORF was used in con-
junction with an antisense oligonucleotide complementary to the 3
 
9
 
 end of
the Nup98 ORF (ending with proline 912). The oligonucleotide also con-
tained an additional 18 nt coding for the 6 COOH-terminal amino acids of
full-length human Nup98 that are not encoded by the Nup98-Nup96 pre-
cursor site (see Borrow et al., 1996; Nakamura et al., 1996) and a NotI re-
striction site. The resulting PCR product was digested with SalI and NotI
and ligated into the SalI/NotI sites of myc-pAlter-MAX. The cleaved
form of Nup98 (amino acids 1–863) was also generated by PCR using the
wild-type Nup98-Nup96 cDNA as template, and the resulting PCR prod-
uct was cloned into the SalI/NotI sites of myc-pAlter-MAX.
The Nup98-Nup96 precursor double mutant (F863S/Y866R), and the
similar Nup98 double mutant, were generated by recombinant PCR using
mismatched primers and the myc-tagged Nup98-Nup96 precursor cDNA
as template (Higuchi, 1990).
 
Peptide Sequence Analysis
 
Proteins from fractionated nuclear envelope were separated by SDS-
PAGE and transferred to polyvinylidene difluoride membrane. The ap-
propriate proteins were excised after identification by staining with Pon-
ceau S. The proteins were extracted or were digested on the membrane
with endoproteinase Lys-C. Peptides were separated and sequenced as
previously described (Fernandez et al., 1994).
 
Expression of Recombinant Segment of Nup96 and 
Antibody Production
 
For protein production, a DNA fragment corresponding to amino acids
1291–1482 of the Nup98-Nup96 precursor was obtained by PCR and
cloned into the NdeI and AvaI sites of the bacterial expression vector
pET21a (Novagen, Inc.). 
 
E. coli
 
 strain BL21 (DE3) pLysE was trans-
formed with the expression vector, and expression of the recombinant
protein was induced by adding 0.2 mM isopropyl thio-
 
b
 
-
 
D
 
-galactoside to
the culture media. The recombinant protein was purified by Nickel-NTA
agarose as described by the manufacturer (QIAGEN Inc.).
For antibody production, rabbits were injected with purified, recombi-
nant protein and serum was collected after an appropriate response had
been elicited. Antibodies were purified from the crude serum by affinity
chromatography. The recombinant protein was immobilized on Affi-Gel
15 according to the manufacturer (Bio-Rad Laboratories), and serum was
incubated with the gel for 12 h. The gel was loaded into a column, and the
column was washed with 1 M NaCl in PBS. Bound antibodies were eluted
with 0.1 M glycine (pH 2.5), and the eluate immediately neutralized with
1 M Tris (pH 8.0).
 
SDS-PAGE and Immunoblot Analysis
 
Proteins were separated by SDS-PAGE and transferred to nitrocellulose
membrane as previously described (Dreyfuss et al., 1984). Nitrocellulose
membranes were blocked with 5% nonfat dry milk in PBS containing
0.05% NP-40, and the blots were probed with affinity-purified Nup96 anti-
bodies diluted 1:300 in PBS containing 2% BSA. Nup107 was detected us-
ing an affinity-purified rabbit polyclonal antibody (Radu et al., 1994). An-
tibodies were detected using luminol-based chemiluminescence.
 
Immunofluorescence Microscopy and
Cell Transfections
 
HeLa cells were grown in DME supplemented with 10% fetal calf serum.
For immunofluorescence, cells were grown overnight on coverslips,
washed in PBS, fixed in 2% formaldehyde/PBS for 30 min at room tem-
perature, and permeabilized with 
 
2
 
20
 
8
 
C acetone for 3 min. Affinity-puri-
fied Nup96 antibodies (diluted 1:300), the anti-myc monoclonal antibody
9E10 (Evan et al., 1985; diluted 1:1,000), and rabbit anti-Nup358 antibod-
ies (Wu et al., 1995; diluted 1:500) were incubated with the cells for 1 h at
room temperature. Cells were washed in PBS and incubated with either
fluorescein-conjugated goat anti–rabbit (Organon/Teknika), and/or Cy3-
conjugated donkey anti–mouse (Jackson ImmunoResearch) antibodies
for 30 min at room temperature. Cells were washed again in PBS and
mounted in 80% glycerol, 50 mM Tris-HCl (pH 8.0), 0.1% 
 
p
 
-phenylenedi- 
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amine. Samples were analyzed with a Zeiss laser scanning confocal micro-
scope.
For transfections, HeLa cells were grown on 35-mm dishes and were
transfected with 2 
 
m
 
g of DNA using lipofectamine (GIBCO-BRL) accord-
ing to the manufacturer’s instructions. After 36 h, cells were assayed ei-
ther by immunofluorescence microscopy or by immunoblot analysis as de-
scribed above.
 
Immunogold Electron Microscopy
 
Rat liver nuclear envelopes were prepared as described above. Isolated
nuclear envelopes were fixed for 15 min in 2.5% formaldehyde in STM
(10% sucrose, 20 mM triethanolamine-HCl, pH 7.5, 0.1 mM MgCl
 
2
 
) and
centrifuged at 2,000 
 
g
 
 for 5 min onto 35-mm tissue culture dishes. The pel-
leted nuclear envelopes were washed three times with 1% BSA, 68 mM
NaCl, 13 mM KCl, 15 mM KH
 
2
 
PO
 
4
 
, 40 mM Na
 
2
 
HPO
 
4
 
, and 0.5 mM PMSF
and then incubated with affinity-purified anti-Nup96 antibodies diluted
1:300, and mouse monoclonal antibody 19C7 (specific for RanGAP1; Ma-
tunis et al., 1996), or mouse monoclonal antibody 5E10 (specific for Tpr;
Matunis, M.J., and G. Blobel, unpublished data) diluted 1:1,000. Bound
antibodies were detected with goat anti–rabbit IgG conjugated with 10-nm
gold, or goat anti–mouse IgG conjugated with 5-nm gold (Amersham Life
Science Inc.).
For in situ labeling of intact cells, HeLa cells grown on 35-mm tissue
culture dishes were first permeabilized with digitonin (50 
 
m
 
g/ml) for 5 min
at room temperature, fixed with 2% formaldehyde in PBS for 30 min at
room temperature, incubated with primary and secondary antibodies as
indicated above and processed for thin sectioning and EM as previously
described (Pain et al., 1990).
 
In Vitro Transcription/Translation Assays
 
All Nup98 and Nup98-Nup96 precursor proteins were synthesized in rab-
bit reticulocyte lysate transcription and translation extracts, in the presence
of [
 
35
 
S]methionine, as described by the manufacturer (Promega Corp.).
Proteins were separated by SDS-PAGE and analyzed by autoradiography.
 
Results
 
Nup96 Is a Novel Nucleoporin Associated with the 
Nucleoplasmic Side of the NPC
 
We have developed a novel procedure for purifying the
protein components of the mammalian NPC (Matunis et al.,
1996). In the final step of this procedure, NPCs are solubi-
lized and released from the nuclear lamina by extraction
with the zwitterionic detergent, Empigen BB. The Empi-
gen BB supernatant fraction contains all of the currently
known nucleoporins, in addition to 
 
z
 
30 uncharacterized,
candidate nucleoporins (Fig. 1). One of the major unchar-
acterized proteins, with an apparent molecular mass of 115
kD (indicated by the asterisk in Fig. 1), was analyzed by
peptide sequence analysis, and the peptide sequence was
used to isolate a full-length cDNA clone encoding this
protein (see following sections). Based on its predicted
molecular mass of 96 kD, and its association with NPCs,
this novel nucleoporin has been termed Nup96. Nup96
runs anomalously at 115 kD by SDS-PAGE.
To produce antibodies specific for Nup96, a 22-kD frag-
ment (corresponding to residues 1291–1482 of the pre-
dicted full-length protein; see Fig. 5) was expressed in 
 
E.
coli
 
 and injected into rabbits. Affinity-purified antibodies
reacted with Nup96, as indicated by immunoblot analysis
of SDS-PAGE separated proteins of total nuclei and iso-
lated nuclear envelopes (Fig. 2 A). Fractionation of iso-
lated rat liver nuclei showed that Nup96 is associated pre-
dominantly with the nuclear envelope (Fig. 2 A, lane 2),
although a significant fraction was also detected in the nu-
cleoplasmic fraction (Fig. 2 A, lane 3), consistent with
the immunofluorescence data (see below). In addition to
Nup96, the affinity-purified antibodies also recognized a
200-kD protein that fractionated exclusively with the solu-
ble nucleoplasm (Fig. 2 A, lane 3). As Nup96 is synthe-
sized as a 186-kD protein that is proteolytically cleaved in
vivo (see following sections), this 200-kD protein could
represent the intact precursor. However, a similar band is
not detected with antibodies to Nup98 (data not shown),
and pulse-labeling experiments indicate that the precursor
has a very short half-life (data not shown). Therefore, it is
more likely that this band corresponds to a cross-reacting
protein unrelated to the Nup98-Nup96 precursor.
By indirect immunofluorescence microscopy Nup96
showed a rim-like staining at the midplane of the nucleus
(Fig. 2 B). The nuclear envelope staining became more
diffuse and punctate upon focusing near the surface of the
nucleus (data not shown). This labeling pattern is charac-
teristic of that observed for other nucleoporins (Davis and
Blobel, 1986; Radu et al., 1995), and is further evidence for
the association of Nup96 with NPCs. In addition to nuclear
envelope staining, a weak intranuclear signal was also ob-
served. This signal may be attributed to the presence of
Nup96 within the nucleus, and/or to the 200-kD protein
with which the Nup96 antibodies cross-react (see Fig. 2 A,
lane 3). Signal was excluded from the nucleoli.
To further sub-localize Nup96 at the level of the NPC,
immunogold EM was performed using anti-Nup96 anti-
bodies. When isolated rat liver nuclear envelopes were
probed, Nup96 was detected specifically at the nucleoplas-
mic face of the NPCs (Fig. 3, A–D). Gold particles were
Figure 1. Identification of
Nup96, a novel nucleoporin
with an apparent molecular
mass of 115 kD. Nucleoporins
were purified from isolated
rat liver nuclear envelopes,
separated by SDS-PAGE,
and stained with Coomassie
brilliant blue. A previously
uncharacterized protein mi-
grating at 115 kD (indicated
by an asterisk) was analyzed
by peptide sequence analysis.
Additional known nucleopor-
ins are indicated. Numbers at
left indicate Mr markers. 
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distributed over a range from 22 to 50 nm from the mid-
plane of the nuclear envelope, with a mean distance of 36 nm
(
 
n
 
 5 
 
50). The relative position of Nup96 in the NPC was
established by double labeling experiments using mono-
clonal antibodies to RanGAP1 (Fig. 3, A and B) and Tpr
(Fig. 3, C and D), markers for cytoplasmic and nucleoplas-
mic fibers of the NPC, respectively (Matunis et al., 1996;
Cordes et al., 1997). Nup96 was located at or near the nu-
cleoplasmic basket of the NPC, on the opposite face com-
pared with RanGAP1, and in close proximity to Tpr.
Because components of the NPC fibers may be lost or
the fibers may collapse during isolation of nuclear enve-
lopes, we also examined the localization of Nup96 in intact
cells. Cells were permeabilized using digitonin, fixed and
labeled with both primary and secondary antibodies be-
fore processing and sectioning for EM. Under these condi-
tions, the relative distributions of Nup96 (Fig. 3, E–H),
RanGAP1 (Fig. 3, E and F), and Tpr (Fig. 3, G and H) re-
mained the same, confirming the results obtained using
isolated nuclear envelopes. However, the distance of Nup96
from the mid-plane of the nuclear envelope was dramati-
cally greater in the intact cells (averaging 100–200 nm),
compared with the distance observed with isolated nuclear
envelopes (averaging 36 nm). This difference could be due
to the collapse of the nucleoplasmic basket and/or at-
tached filaments upon isolation of nuclear envelopes.
 
Nup96 cDNAs Predict a Nup96/Nup98 Precursor
 
The internal peptide sequence LVVRHLASDAIINE-
NYD derived from Nup96 was used to search sequence
databases for candidate cDNA clones coding for Nup96. A
partial cDNA clone was identified, GM2B8, that con-
tained sequences coding for this peptide. GM2B8 was
originally derived from a mouse macrophage subtraction
library designed to identify messenger RNAs induced by
interferon-
 
g
 
 (Yang et al., 1995). Screening a HeLa cell
cDNA library with a GM2B8 probe and subsequent 5
 
9
 
RACE yielded full-length clones coding for Nup96 (see
Materials and Methods).
Surprisingly, the longest full-length clone obtained pre-
dicted a protein of 1,712 amino acids, with a molecular
mass of 186 kD (Fig. 4). This size was in contrast to the ex-
pected 115 kD determined by SDS-PAGE (Fig. 1). Analy-
sis of the predicted amino acid sequence of this clone re-
vealed that the NH
 
2
 
-terminal 914 residues are identical to
the previously characterized nucleoporin, Nup98 (Radu
et al., 1995; Borrow et al., 1996; Nakamura et al., 1996),
whereas the remaining 798 COOH-terminal residues are
unique and contain the sequenced peptide derived from
Nup96. Because this predicted protein contains sequences
identical to both Nup98 and Nup96, it will be referred to as
the Nup98-Nup96 precursor. Previously identified, com-
plete cDNA clones for Nup98 predict a protein product of
920 amino acids (Radu et al., 1995; Borrow et al., 1996;
Nakamura et al., 1996). The Nup98-Nup96 mRNA does
not contain the last 18 nucleotides coding for the COOH-
terminal 6 amino acids of Nup98. Several lines of evidence
suggest that the mRNA coding for the Nup98-Nup96 pre-
cursor, and the previously described Nup98 mRNA, are
derived from a common, alternatively spliced pre-mRNA.
First, the nucleotide sequences in both the 5
 
9
 
 untranslated
regions and in the Nup98 coding regions are 100% identi-
cal between both mRNAs (Fig. 5 A). Second, Northern
blot analysis with a Nup98-specific probe revealed multi-
ple RNA transcripts of 
 
z
 
4, 6, 6.5, and 7 kb (Fig. 5 B, lane
1). A Nup96-specific probe detected similar 6-, 6.5-, and
7-kb transcripts, but not a 4-kb transcript (Fig. 5 B, lane 2).
These data suggest that the larger transcripts code for the
Nup98-Nup96 precursor, whereas the shorter 4-kb tran-
script codes independently for Nup98.
With regard to the three Nup98-Nup96 precursor tran-
scripts detected by Northern blot analysis, two classes of
cDNAs were isolated during the screen for Nup96 clones.
These cDNAs encode identical proteins, with the excep-
tion of a 75–amino acid insert predicted by the longer
clone (see Fig. 4). Because the protein containing this 75–
amino acid insert comigrates with endogenous Nup96 (see
Fig. 7 B), whereas the protein without this insert does not
(data not shown), the longer clone was used for subse-
quent analysis.
When the entire Nup98-Nup96 precursor sequence was
aligned to all previously known proteins, significant ho-
Figure 2. Nup96 is a component of the mammalian NPC. (A) Im-
munoblot analysis of fractionated rat liver nuclei. Total nuclei
were fractionated into nuclear envelope and nucleoplasm, and
equivalent amounts of each fraction (corresponding to 1 3 106
nuclei) were separated by SDS-PAGE, transferred to nitrocellu-
lose membrane, and probed with antibodies against Nup96.
Nup96 is the major protein detected in total nuclei (lane 1), and it
fractionates predominantly with the nuclear envelope fraction
(lane 2). A significant amount of Nup96, however, is also de-
tected in the nucleoplasm (lane 3). An uncharacterized, cross-
reacting protein of 200 kD (indicated by the asterisk), also frac-
tionates with the nucleoplasm. Molecular masses are indicated on
the left. (B) Immunofluorescence microscopy. HeLa cells were
fixed, permeabilized, and labeled with anti-Nup96 antibodies.
When observed at the equatorial plane of the nucleus, a discon-
tinuous rim was apparent, characteristic of NPC staining. Diffuse
intranuclear labeling was also apparent. Lower panel shows la-
beling at telophase. Bar, 13 mm. 
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mology was observed with the 
 
S. cerevisiae
 
 nucleoporin,
Nup145p, as well as with an ORF located on chromosome
I of 
 
Arabidopsis thaliana
 
 (these data are available from
GenBank/EMBL/DDBJ under accession number U53501),
and a protein predicted by the 
 
Caenorhabditis elegans
 
cDNA, ZK328.5b (accession number U50193; Bailer et al.,
1998). The NH
 
2
 
-terminal domains of the Nup98-96 pre-
cursor, Nup145p, and the 
 
C. elegans
 
 protein, all predict
polypeptides with conserved GLFG repeats. The 
 
A. tha-
liana
 
 protein does not contain a GLFG-repeat domain.
Near the middle of the Nup98-Nup96 precursor, Nup145p,
and the 
 
C. elegans
 
 protein, and near the NH
 
2
 
 terminus of
the 
 
A. thaliana
 
 protein, is a highly conserved domain
(
 
z
 
40% identical between homologues; Fig. 6). This do-
main is of particular interest, because in 
 
S. cerevisiae
 
,
Nup145p is posttranslationally cleaved at a site near the
COOH-terminus of the domain (after the phenylalanine
at position 605), thereby generating two independent nu-
cleoporins, N-Nup145p and C-Nup145p (Dockendorff et
al., 1997; Emtage et al., 1997; Teixeira et al., 1997). The
Figure 3. Immunolocalization
of Nup96 to the nucleoplasmic
face of the NPC. Isolated rat
liver nuclear envelopes were
probed with rabbit anti-Nup96
antibodies (A–D) and the
mouse anti-RanGAP1 mAb
19C7 (A and B), or the mouse
anti-Tpr mAb 5E10 (C and
D). Rabbit antibodies were
detected with 10 nm gold-cou-
pled secondary antibodies,
whereas mouse antibodies
were detected with 5-nm gold-
conjugated secondary antibod-
ies. Envelopes were processed
for thin sectioning and ob-
served by EM. The cytoplas-
mic face of the nuclear enve-
lopes (as evident from
differences in the morphology
of the nuclear and cytoplasmic
membranes) are oriented to-
ward the top of each micro-
graph. Intact HeLa cells were
also probed simultaneously
with rabbit anti-Nup96 anti-
bodies (E–H) and the mouse
anti-RanGAP1 mAb 19C7 (E
and F), or the mouse anti-Tpr
mAb 5E10 (G and H). Rabbit
antibodies were detected with
10-nm gold-coupled second-
ary antibodies, whereas mouse
antibodies were detected with
5-nm gold-conjugated second-
ary antibodies. The cells were
processed for thin sectioning
and observed by EM. The cy-
toplasm of the cells is oriented
towards the top of each micro-
graph. Bar, 0.1 mm. 
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high conservation of the cleavage site and surrounding res-
idues between yeast, plant, worm, and mammal suggested
that the posttranslational processing pathway may be
conserved and functionally important. After the highly
conserved cleavage site, all four proteins continue to be
homologous over their entire length (Fig. 6). The COOH-
terminal domains are rich in leucine and serine and
contain a surprising number of conserved tryptophan
residues. However, no obvious motifs or homologies to
proteins with known functions were identified.
Figure 4. Amino acid se-
quence and schematic repre-
sentation of the predicted
Nup98-Nup96 precursor. The
box indicates the NH2-termi-
nal domain homologous to
Nup98. Heavy underlines in-
dicate amino acids identified
through direct protein se-
quence analysis. The thin un-
derline indicates a putative,
alternative exon absent from
a second class of Nup98-
Nup96 precursor cDNAs.
Arrow and arrowheads, be-
tween phenylalanine 863 and
serine 864, indicate the pro-
teolytic cleavage site.
Figure 5. Alternatively spliced mRNAs code
for Nup98 and for a Nup98-Nup96 precursor.
(A) Schematic representation of Nup98 and
Nup98-Nup96 precursor mRNAs. The 59-
UTRs of both mRNAs are identical except
for the first 17 nucleotides, which are absent
in the Nup98-Nup96 mRNA. The Nup98 cod-
ing regions are identical, except that the
Nup98-Nup96 mRNA does not contain the
last 18 nucleotides coding for the COOH-ter-
minal 6 amino acids of Nup98. The Nup98-
Nup96 mRNA has an extended coding region
(shown in black) that generates Nup96. Both
mRNAs have different 39-UTRs. (B) North-
ern blot analysis of Nup98 and Nup98-Nup96
precursor mRNA transcripts. Poly(A)1 RNA
was purified from HeLa cells, separated by
agarose gel electrophoresis, and transferred
to nitrocellulose membranes. Membranes
were probed with a Nup98-specific probe
(lane 1), or a Nup96-specific probe (lane 2).
Approximate size markers (in kb) are indi-
cated on the left. 
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Nup98 and Nup96 Are Generated through Proteolytic 
Processing of the Nup98-Nup96 Precursor
 
The isolation of cDNA clones for Nup96 that predict a
protein product of 186 kD, and the similarity between this
protein product and 
 
S. cerevisiae
 
 Nup145p, prompted us
to investigate whether proteolytic processing of the Nup98-
Nup96 precursor may also occur. The first approach to-
ward addressing this issue was to determine the NH
 
2
 
-ter-
minal residue of Nup96 by direct amino acid sequence
analysis. As indicated in Fig. 4, the NH
 
2 
 
terminus of Nup96
was found to begin with the serine residue at position 864
of the full-length Nup98-Nup96 precursor. This serine is in
exact alignment with a serine at the cleavage site in
Nup145p, suggesting that the Nup98-Nup96 precursor is
proteolytically processed through a mechanism similar to
that occurring with Nup145p in yeast.
To further investigate the proteolytic processing of the
Nup98-Nup96 precursor and its functional significance, var-
ious constructs were designed to express epitope tagged
versions of the protein, both in vitro and in vivo (Fig. 7 A).
In particular, a mutant of Nup98-Nup96, predicted to be
resistant to proteolytic cleavage, was designed using know-
Figure 6. Amino acid sequence alignments of the COOH-terminal portion of Nup98-Nup96 and putative homologues in S. cerevisiae
(Nup145p), A. thaliana (accession number U53501), and C. elegans (accession number U50193). The box indicates the highly conserved
domain preceding the cleavage site between Nup98 and Nup96. Amino acids are numbered from the presumed initiating methionine in
each protein. Identical amino acids are shaded. 
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ledge of mutations made in 
 
S. cerevisiae
 
 Nup145p (Teix-
eira et al., 1997). This mutant contains two amino acid sub-
stitutions near the predicted cleavage site (F863S and
Y866R). Proteolytic processing of the wild-type Nup98-
Nup96 precursor was initially assayed using an in vitro
transcription/translation system. Consistent with proteolytic
cleavage of a precursor protein, two protein products were
produced by transcription/translation of the wild-type
Nup98-Nup96 precursor in rabbit reticulocyte lysate (Fig.
7 B, lane 2). The lower band comigrated with the myc-
tagged Nup98 domain expressed alone (Fig. 7 B, lane 4),
whereas the upper band migrated with a similar mobility
to the myc-tagged Nup96 domain (Fig. 7 B, lane 5). Al-
though the Nup96 domain has a predicted 
 
M
 
r
 
 of 96 kD, its
mobility by SDS-PAGE is closer to 115 kD. This anoma-
 
lous mobility is consistent with the mobility of the protein
initially identified in the rat liver NPC preparation (Fig. 1).
These data indicate that rabbit reticulocyte lysate con-
tains the necessary factor(s) for the processing of the
Nup98-Nup96 precursor. Therefore, the Nup98-Nup96 pre-
cursor with mutations near the cleavage site was tran-
scribed and translated using identical conditions. A pro-
tein of 
 
z
 
210 kD was produced using this mutant, a size
consistent with the predicted mobility of the uncleaved
precursor (Fig. 7 B, lane 3). Taken together, these in vitro
data support the conclusion that the Nup98-Nup96 precur-
sor is proteolytically processed to generate two nucleopor-
ins, Nup98 and Nup96. To further demonstrate that the
cleavage of the Nup98-Nup96 precursor occurs in vivo, the
myc-tagged wild-type and mutant plasmids encoding for
proteins were transfected into cells in culture. Immunoblot
analysis of lysate from cells transfected with the wild-type
protein revealed a major band (only the NH
 
2
 
 terminus of
the precursor contains a myc-tag) migrating at 
 
z
 
100 kD
(Fig. 7 C, lane 2), consistent with the predicted size of the
myc-tagged Nup98 domain after cleavage. Analysis of ly-
sate from cells transfected with the mutant Nup98-Nup96
precursor, on the other hand, revealed a major protein of
z210 kD. These results demonstrate that the Nup98-
Nup96 precursor is proteolytically processed in vivo.
Synthesis and Processing of the Nup98-Nup96 
Precursor Is Required for Proper Targeting of Nup98 
and Nup96 to the NPC
In  S. cerevisiae, synthesis and cleavage of the Nup145p
precursor is important for some aspects of targeting the re-
sulting nucleoporins (N-Nup145p and C-Nup145p) to the
NPC (Fabre et al., 1994; Teixeira et al., 1997). To examine
the effects and requirements of Nup98-Nup96 precursor
synthesis and processing on Nup98 and Nup96 localiza-
tion, cultured cells were transfected with the various con-
structs illustrated in Fig. 7 A, and the localization of the
expressed proteins was determined by indirect immuno-
fluorescence confocal microscopy. Cells were double la-
beled with an anti-myc antibody to localize the transiently
expressed proteins, and an antibody to Nup358, a marker
for NPCs. When the NH2-terminal tagged, wild-type Nup98-
Nup96 precursor was expressed, labeling of the nuclear
envelope was observed, indicating targeting of the cleaved
Nup98 domain to the NPC (Fig. 8 A). Labeling of nucleoli
was also observed in many cells expressing high levels of
protein, possibly a consequence of having saturated bind-
ing sites for Nup98 at the NPC or a possible intranuclear
localization of Nup98 as previously described (Powers et
al., 1995). Merging the signals for Nup358 (Fig. 8 B) and
Nup98 revealed coincident labeling of the nuclear enve-
lope (Fig. 8 C), confirming NPC targeting.
The cleavage-deficient mutant of the Nup98-Nup96 pre-
cursor was next examined. In this case, only intranuclear
labeling was observed, with no evidence of association of
the precursor protein with NPCs or nucleoli (Fig. 8 D).
Again, cells were double labeled with antibody to Nup358
(Fig. 8 E), and the merged images revealed no detectable
overlap between the two signals at the nuclear envelope
(Fig. 8 F). This result indicates that cleavage is a prerequi-
site for NPC localization of Nup98. Expression of the
Figure 7. The Nup98-Nup96 precursor is proteolytically pro-
cessed in vitro and in vivo. (A) Schematic representation of the
Nup98-Nup96 precursor protein constructs used in the in vitro
and in vivo expression assays. Each protein contains a myc-
epitope tag (shown in gray) at its NH2 terminus. (B) In vitro tran-
scription/translation reactions. Protein constructs were transcribed
and translated in rabbit reticulocyte lysates in the presence of
[35S]methionine. Reactions were separated by SDS-PAGE and
analyzed by autoradiography. Reactions were performed with no
DNA (lane 1), wild-type Nup98-Nup96 precursor (lane 2),
mutant Nup98-Nup96 precursor (F863S/Y866R) (lane 3), Nup98
(1–863; lane 4), and Nup96 (lane 5). Molecular mass markers are
indicated on the left. (C) In vivo expression of the wild-type and
mutant Nup98-Nup96 precursors. HeLa cells were transfected
with no DNA (lane 1), wild-type Nup98-Nup96 precursor (lane
2) and mutant Nup98-Nup96 precursor (F863S/Y866R) (lane 3).
24 h after transfection, cells were lysed in sample buffer and ana-
lyzed by immunoblot analysis using an anti-myc epitope anti-
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Nup98 domain alone (amino acids 1–863) resulted in a
localization that was virtually indistinguishable from the
localization observed after expression of the wild-type
Nup98-Nup96 precursor, revealing that it could be tar-
geted to the NPC independent of being synthesized as
a precursor with Nup96 (Fig. 8, G–I). However, when
Nup96 was expressed independently, a diffuse cytoplasmic
signal was detected, with very little if any detectable local-
Figure 8. Proteolytic processing of the Nup98-Nup96 precursor is essential for targeting Nup98 and Nup96 to the NPC. HeLa cells were
transiently transfected with: (A–C) the wild-type Nup98-Nup96 precursor, (D–F) the mutant Nup98-Nup96 precursor (F863S/Y866R),
(G–I) the Nup98 domain (amino acids 1–863), and (J–L) Nup96 (amino acids 864–1712). Localization of the transiently expressed pro-
teins was detected by indirect immunofluorescence and confocal microscopy using an anti-myc epitope antibody followed by a Cy3-con-
jugated secondary antibody (A, D, G, and J). Cells were also double labeled with an antibody specific for Nup358, which was detected
using a secondary antibody conjugated to FITC (B, E, H, and K). Cy3 and FITC images were merged to identify coincident labeling of
NPCs (C, F, I, and L). Bar, 10 mm.Fontoura et al. Nup98 and Nup96 Biogenesis 1107
ization at NPCs (Fig. 8 J). Merging the signal obtained
with antibody to Nup358 (Fig. 8 K) with the signal for
Nup96 revealed some overlap at the nuclear envelope,
making it impossible to conclude that the transiently ex-
pressed Nup96 was absolutely excluded from NPCs. Rela-
tive to Nup98, however, Nup96 is not efficiently targeted
to the nucleus, or to NPCs.
Nup98 Is also Proteolytically Processed In Vivo
The cleavage site present in the Nup98-Nup96 precursor
protein is also present in the protein predicted by the
Nup98-specific transcript (Radu et al., 1995; Borrow et al.,
1996; Nakamura et al., 1996). To examine whether the in-
dependently expressed Nup98 protein is proteolytically
processed, mutations were made near the cleavage site,
similar to those made in the Nup98-Nup96 precursor (Fig.
9 A). When a myc-tagged wild-type Nup98 was expressed
in rabbit reticulocyte lysate, a protein with a relative mo-
lecular mass of 100 kD was observed by SDS-PAGE (Fig.
9 B, lane 2). This protein product migrated with a similar
mobility to the myc-tagged Nup98 product consisting of
amino acids 1–863 (Fig. 9 B, lane 4), suggesting that Nup98
is indeed processed. Expression of the mutant Nup98, re-
sulted in the production of a protein with a relative molec-
ular mass of 110 kD, providing additional evidence that
Nup98 is proteolytically cleaved (Fig. 9 B, lane 3). To de-
termine whether cleavage occurs in vivo, the wild-type and
mutant Nup98 proteins were transiently expressed in cul-
tured cells. Immunoblot analysis of cell lysates with an
anti-myc antibody revealed proteins of 100 and 110 kD in
cells transfected with the wild-type and mutant Nup98
proteins (Fig. 9 C, lanes 1 and 2), respectively, indicating
that proteolytic cleavage also occurs in vivo. These results
indicate that the alternatively spliced Nup98 transcripts
each produce identical Nup98 proteins (consisting of amino
acid residues 1–863), through proteolytic processing.
To determine whether the processing of Nup98 influ-
enced its targeting to the NPC, indirect immunofluores-
cence confocal microscopy was performed on cells trans-
fected with the wild-type and mutant proteins using the
double labeling approach indicated above. The wild-type,
cleaved Nup98, was efficiently targeted to the NPC, as
demonstrated in Fig. 10, A–C. Again, labeling of nucleoli
was observed in cells expressing high levels of processed
Nup98. When mature Nup98 (residues 1–863) was tran-
siently expressed, localization to the NPC was also ob-
served (Fig. 8, G–I), indicating that mature Nup98 is im-
ported into the nucleus and targeted to the NPC. In
contrast, mutant uncleaved Nup98 was found to accumu-
late strictly in the nucleoplasm, with no detectable associa-
tion with NPCs (Fig. 10, D–F). In addition, uncleaved
Nup98 was also absent from nucleoli. These data indicate
that, as with the Nup98-Nup96 precursor, proteolytic pro-
cessing of the Nup98 precursor is essential for proper tar-
geting to the NPC.
Nup96 Fractionates with a Complex Containing 
Nup107 and Two Sec13-Related Proteins
To determine whether Nup96 interacts with other nucle-
oporins to form specific sub-domains of the NPC, we car-
ried out subfractionation with isolated rat liver nuclei. We
identified a sub-complex of the NPC that contains Nup96
and at least five additional proteins (Fig. 11). This complex
was released from the pore-complex-lamina fraction using
heparin and detergent, and then analyzed by sucrose gra-
dient centrifugation. One of the proteins found to cosedi-
ment in the gradient with Nup96 had an apparent molecu-
lar mass of 105 kD, similar to the expected mass of Nup107
(Radu et al., 1994). Immunoblot analysis of the sucrose
gradient fractions confirmed that Nup96 and Nup107 co-
sedimented, peaking in fractions 5 and 6 (Fig. 11).
In yeast, a similar complex has been observed between
C-Nup145p and Nup84p, the putative homologues of
Nup96 and Nup107, respectively (Siniossoglou et al., 1996).
This complex also contains a number of additional pro-
teins, including Nup120p, Nup85p, Sec13p, and a Sec13p-
related protein, Seh1p. Two of the proteins that we found
to cosediment with Nup96 had molecular masses that
closely matched the molecular mass of Sec13p (z35 kD).
Therefore, we obtained peptide sequences for these two
proteins (which are indicated by the asterisks in Fig. 11),
Figure 9. Nup98 is proteolytically processed in vitro and in vivo.
(A) Schematic representation of the Nup98 protein constructs
used in the in vitro and in vivo expression assays. Each protein
contains a myc-epitope tag (shown in gray) at its NH2 terminus.
(B) In vitro transcription/translation reactions. Protein constructs
were transcribed and translated in rabbit reticulocyte lysates in
the presence of [35S]methionine. Reactions were separated by
SDS-PAGE and analyzed by autoradiography. Reactions were
performed with no DNA (lane 1), wild-type Nup98 (lane 2), mu-
tant Nup98 (F863S/Y866R) (lane 3), and Nup98 (1–863) (lane 4).
Molecular mass markers are indicated on the left. (C) In vivo ex-
pression of the wild-type and mutant Nup98 precursors. HeLa
cells were transfected wild-type Nup98 (lane 1), mutant Nup98
(F863S/Y866R) (lane 2), and with no DNA (lane 3). 24 hours af-
ter transfection, cells were lysed in sample buffer and analyzed by
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to determine their molecular identity. Two internal pep-
tide sequences obtained from the larger of the two pro-
teins indicated that it was identical to the human homo-
logue of yeast Sec13p, a protein referred to as mSec13 or
Sec13Rp (Shaywitz et al., 1995; Tang et al., 1997). Se-
quence obtained from the second, lower molecular mass
protein (referred to as p37) indicated that it was a novel
protein with limited homology to Sec13p. Full-length
clones coding for this protein will have to be isolated be-
fore a complete comparison can be made with Sec13, and
with the Sec13-related protein (Seh1p) found to copurify
with the homologous yeast complex. In summary, we have
identified a complex released from mammalian NPCs that
contains Nup96, Nup107, mSec13, and a novel Sec13-related
protein.
Discussion
We are using a novel nuclear envelope fractionation pro-
cedure to characterize more completely the protein com-
ponents making up the mammalian NPC. Based on this
fractionation procedure and separation of the isolated
proteins by reverse phase column chromatography, we es-
timate that less than one-third of the mammalian nucle-
oporins have been characterized at the molecular level.
This factor contributes significantly to our lack of under-
standing about how the NPC is assembled, and how it
functions to regulate nucleocytoplasmic transport. The
fractionation procedure that we have developed yields nu-
cleoporins and NPC-associated proteins in high purity and
yield, and has allowed us to identify a significant number
of novel proteins. The first NPC-associated protein that
we characterized using this fractionation procedure was
the SUMO-1 modified form of RanGAP1 (Matunis et
al., 1996). Here, we have reported the characterization of
a second protein, a new nucleoporin of 96 kD termed
Nup96.
The most intriguing aspect of Nup96 is its unusual path-
way of biogenesis. Through analysis at a number of levels,
we have demonstrated that Nup96 is synthesized as a pre-
cursor that is proteolytically cleaved in vivo. Cleavage of
this precursor generates not only Nup96, but also the
GLFG-containing nucleoporin, Nup98. Nup98 can also be
produced independently of Nup96, by what appears to be
an alternatively spliced mRNA that does not include the
Nup96 open reading frame (Radu et al., 1995; Borrow et al.,
1996; Nakamura et al., 1996). Whereas it was not previ-
ously recognized that this predicted Nup98 protein is pro-
teolytically processed, we have shown that it is processed
like the Nup98-Nup96 precursor. Evidence for the synthe-
sis and processing the Nup98-Nup96 precursor and the
Nup98 precursor in vivo are: (a) Northern blot analysis
that supports the existence of the precursor mRNAs, and
isolation of cDNAs that predict the precursor proteins; (b)
NH2-terminal peptide sequence of Nup96 that supports
the cleavage of the Nup98-Nup96 precursor between
phenylalanine 863 and serine 864; (c) mutagenesis of the
cleavage sites that yield the uncleaved precursors, both
in vitro and in vivo; (d) homology with S. cerevisiae
Nup145p, which undergoes posttranslational in vivo cleav-
age at an identical site (Dockendorff, 1997; Emtage et al.,
1997; Teixeira et al., 1997).
The Nup98-Nup96 precursor is the apparent vertebrate
homologue of S. cerevisiae Nup145p. The NH2 terminus of
both proteins, Nup98 and N-Nup145p, are z20% identical
over their entire length and contain highly conserved
GLFG repeats. N-Nup145p is not essential, but it may
have RNA-binding activity and function in RNA transport
in yeast (Fabre et al., 1994; Emtage, 1997; Teixeira et al.,
1997). In vertebrates, Nup98 is located on the nucleoplas-
mic side of the NPC, at or near the basket, consistent with
a possible role in RNA export (Radu et al., 1995). Further
supporting such a role, antibodies against Nup98 inhibit
export of multiple classes of RNAs when injected into the
nuclei of Xenopus oocytes (Powers et al., 1997). The
Figure 10. Proteolytic pro-
cessing of Nup98 is essential
for NPC targeting. HeLa
cells were transiently trans-
fected with: (A–C) wild-type
Nup98, (D–F) mutant Nup98
(F863S/Y866R). Localization
of the transiently expressed
proteins was detected by in-
direct immunofluorescence
and confocal microscopy us-
ing an anti-myc epitope anti-
body followed by a Cy3-con-
jugated secondary antibody
(A and D). Cells were also
double labeled with an anti-
body specific for Nup358,
which was detected using a
secondary antibody conju-
gated to FITC (B and E).
Cy3 and FITC images were
merged to identify coincident
labeling of NPCs (C and F).
Bar, 10 mm.Fontoura et al. Nup98 and Nup96 Biogenesis 1109
COOH-terminal domains of both precursors, Nup96
and  C-Nup145p, are also 20% identical over their entire
length, but contain no obvious motifs or homologies to
proteins of know function. Studies in yeast, nonetheless,
indicate a role for C-Nup145p in mRNA export (Docken-
dorff, 1997; Emtage, 1997; Teixeira et al., 1997). Like
Nup98, Nup96 also localizes to the nucleoplasmic side of
the NPC, at or near the basket, consistent with a potential
role in mRNA export. Our data obtained from in situ la-
beling of intact cells indicate that Nup96 may be located
near the distal end of the nucleoplasmic basket, in proxim-
ity to the site where Tpr associates with the NPC.
Of particular interest is the domain around the Nup98-
Nup96 cleavage site, as it is especially conserved among
protein homologues in yeast, plant, worm, and man. A
similar domain is also present at the extreme COOH-ter-
minus of two additional yeast GLFG repeat-containing
nucleoporins, Nup100p and Nup116p (Wente et al., 1992;
Radu et al., 1995; Teixeira et al., 1997). In particular, the
z50 amino acids preceding the cleavage site, and the z12
amino acids after the cleavage site, are z40% identical be-
tween yeast and human (relative to 20% identity between
other regions of the proteins), suggesting that this region
may be important for the cleavage process. Surprisingly,
however, a large portion of this highly conserved domain
is not required for proteolytic processing of Nup145p in
vivo (Emtage et al., 1997). This raises the possibility that
the domain preceding the cleavage site may have another
function, a function that could possibly be regulated by the
cleavage process. This domain includes a conserved RNP1
consensus site that has been suggested to contribute to
the RNA-binding properties of N-Nup145p (Fabre et al.,
1994). It will be interesting to determine whether the
RNA-binding properties of either Nup98 or N-Nup145p
are affected by proteolytic cleavage. The conserved resi-
dues surrounding the cleavage site itself, H-F-S, do not re-
semble the consensus site for any known protease, and the
exact mechanism for the cleavage process remains to be
elucidated. It is also unclear when, or where the cleavage
event occurs, although pulse labeling experiments indicate
that the Nup98-Nup96 precursor is cleaved within five
minutes of being synthesized (data not shown).
Whereas the physiological relevance of producing both
Nup98 and Nup96 through proteolytic cleavage of a pre-
cursor is not known, the conservation of this pathway from
yeast to human suggests a potentially important function.
Posttranslational proteolytic cleavage of precursor pro-
teins is widely used to regulate many different cellular
functions. Processing of many neuropeptides, hormones
and certain plasma proteins is used to regulate the forma-
tion of mature, active factors without the need for de novo
protein synthesis (Resnick and Zasloff, 1992; Seidah and
Chretien, 1997). Protelolytic cleavage can also function to
indirectly activate proteins by regulating their localization
within the cell. Examples include the signal-mediated nu-
clear targeting of Notch-1 from the plasma membrane
Figure 11. Identification of a complex containing
Nup96, Nup107, and Sec13. Rat liver nuclei were
fractionated as described in Materials and Meth-
ods. A fraction containing soluble NPCs was
loaded onto a 10–40% sucrose gradient and cen-
trifuged. Gradient fractions were collected and
analyzed by SDS-PAGE followed by silver stain
analysis (top), or immunoblot analysis with anti-
bodies specific for Nup96 and Nup107 (bottom).
Fractions, numbered from the top of the gradi-
ent, are indicated. Asterisks between lanes 5 and
6 (top) indicate proteins that sediment as a com-
plex. Some of the proteins comprising this com-
plex are indicated on the right.The Journal of Cell Biology, Volume 144, 1999 1110
(Schroeter et al., 1998), and relocalization of the sterol
regulatory element binding proteins from the nuclear mem-
brane to the nucleus in response to sterol levels (Brown
and Goldstein, 1997). Other possible functions of precur-
sor synthesis and proteolytic cleavage include protein
folding, as has been suggested for certain ribosomal pro-
tein-ubiquitin precursors (reviewed by Johnson and Hoch-
strasser, 1997), and as a mechanism to strictly control pro-
tein stoichiometry. Another important role for regulated
proteolytic cleavage is in the assembly and maturation of
large molecular complexes, best exemplified by virus par-
ticle assembly (reviewed in Krausslich and Welker, 1996).
By this analogy, proteolytic cleavage of nucleoporins
could be related to the orderly assembly of the NPC. As
an example, the Nup98-Nup96 precursor could be inserted
into a newly synthesized pore and cleaved only after the
appropriate cleavage factor is assembled. Cleavage may
then result in conformational changes, or exposure of
binding sites on Nup98 and/or Nup96, that allow other sets
of proteins to bind in an orderly sequence.
Our data demonstrate that proper processing of both
the Nup98-Nup96 precursor and the Nup98 precursor is
required for efficient NPC association, indicating that
there is an ordered series of events leading to the associa-
tion of these nucleoporins with the NPC. Mutations in the
cleavage site that prevent processing lead to accumulation
of both proteins in the nucleoplasm, but not at NPCs. In
the case of Nup98, this result suggests that the COOH-ter-
minal 58 amino acids (that would normally be removed)
either tether Nup98 to intranuclear sites, or mask the
NPC-targeting domain. Interestingly, in addition to not
being targeted to NPCs, unprocessed Nup98 was also ab-
sent from nucleoli when over expressed. Although the sig-
nificance of processed Nup98 appearing in nucleoli is not
clear, it has previously been suggested that Nup98 may
not be absolutely confined to NPCs (Powers et al., 1995).
These data raise the intriguing possibility that Nup98
could shuttle between nucleoli and NPCs.
In addition to cleavage being important, our studies also
demonstrate that proper targeting of Nup98 and Nup96 to
the NPC is influenced by the synthesis of the precursor
protein. In particular, we found that targeting of Nup96 to
the NPC is dependent on its being synthesized as a precur-
sor. When expressed independently, Nup96 accumulates
in the cytoplasm, suggesting that its nuclear import may be
Nup98-mediated (Nup98 expressed alone is imported into
the nucleus). Nup98-mediated import of Nup96 could oc-
cur in one of two ways. Either the Nup98-Nup96 precursor
could be imported into the nucleus before proteolytic pro-
cessing, or Nup98 and Nup96 could remain associated af-
ter proteolytic processing in the cytoplasm, and then be
imported as a complex. At present, there is no data to sug-
gest that Nup98 and Nup96 remain associated with each
other once they are inserted into the NPC. The sub-
complex of nucleoporins containing Nup96, Nup107, and
mSec13 that we isolated does not contain Nup98, and ex-
periments in yeast indicate that the analogous sub-com-
plex also lacks N-Nup145p (Teixeira et al., 1997).
To date, relatively few sub-complexes of the mammalian
NPC have been identified. And although strikingly similar
at a morphological level (Yang et al., 1998), no homolo-
gous sub-complexes of mammalian and yeast NPCs have
previously been identified. This has raised the notion that
the molecular structure of the NPC may be less well con-
served than its morphological structure. We have identi-
fied a complex of mammalian nucleoporins that contains
Nup96, Nup107, mSec13, at least one Sec13-related pro-
tein, and at least two additional proteins of z150 kD. This
complex is highly similar to the Nup84p complex of yeast,
and therefore represents one of the first homologous com-
plexes of nucleoporins identified between yeast and mam-
mals. There is also evidence for homology between a yeast
nucleoporin complex containing Nup159p, Nup82p, and
Nsp1p and a vertebrate complex containing Nup214/CAN,
Nup88, and possibly p62 (Macaulay et al., 1995; Bastos et al.,
1997; Fornerod et al., 1997; Belgareh et al., 1998). The
identification of these complexes suggests that the molecu-
lar structure of the NPC may be more highly conserved
than was anticipated. Similarly, homologous sub-com-
plexes will likely be identified in the future, as more mam-
malian and yeast nucleoporins are identified and charac-
terized. In the immediate future, further purification of
this complex will allow us to identify several additional
nucleoporins, and possibly obtain information about its
structural features. Of particular interest is the presence of
the Sec13-related proteins in this complex. Whereas the
exact role that Sec13 may have at the NPC has been previ-
ously discussed (Siniossoglou et al., 1996), our combined
data suggest that this function is likely to be exerted on the
nucleoplasmic side of the NPC, given the localization
Nup96. It will be interesting to investigate the role that
Sec13 may have in NPC biogenesis using Xenopus nuclear
envelope reconstitution systems.
What are the functions of Nup98 and Nup96 once as-
sembled into the NPC? As indicated, both Nup98 and
Nup96 localize to the nucleoplasmic side of the NPC, at or
near the basket. The nucleoplasmic basket appears to have
an active role in binding RNP complexes and mediating
their export from the nucleus. Electron micrographs of
Balbiani ring RNPs being transported through the NPC
show intimate interactions between the basket and the
RNP, implying that the proteins in this structure actively
engage the particles during transport (Kiseleva et al.,
1996). It is not yet known whether the nucleoporins at the
basket bind the RNA itself, and/or the hnRNP proteins
that accompany the RNA during transport (Nakielny et al.,
1997). As implied from their localization, and the func-
tional studies of Nup145p in yeast and Nup98 in Xenopus,
Nup98 and Nup96 are likely to be important factors medi-
ating the docking and translocation of RNPs through the
NPC. The challenge ahead will be to understand how
these nucleoporins interact with RNPs as they are trans-
ported through the NPC, and how these interactions regu-
late the transport process.
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